Ubiquinone dehydrogenase deficiency
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Here, we used Massively Parallel Sequencing to identify a homozygous splicing mutation in the gene encoding Ubiquinol-Cytochrome c Reductase Complex Assembly Factor 2 (UQCC2) in a consanguineous Lebanese patient displaying complex III deficiency, severe intrauterine growth retardation, neonatal lactic acidosis and renal tubular dysfunction.
|
24385928 |
2013 |
Ubiquinone dehydrogenase deficiency
|
0.020 |
Biomarker
|
disease |
BEFREE |
Defects in five further factors for assembly (TTC19, UQCC2, and UQCC3) or iron-sulphur cluster loading (BCS1L and LYRM7) cause complex III deficiency.
|
28804536 |
2017 |
Acidosis, Lactic
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Here, we used Massively Parallel Sequencing to identify a homozygous splicing mutation in the gene encoding Ubiquinol-Cytochrome c Reductase Complex Assembly Factor 2 (UQCC2) in a consanguineous Lebanese patient displaying complex III deficiency, severe intrauterine growth retardation, neonatal lactic acidosis and renal tubular dysfunction.
|
24385928 |
2013 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Epilepsy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Hodgkin Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Renal tubular disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here, we used Massively Parallel Sequencing to identify a homozygous splicing mutation in the gene encoding Ubiquinol-Cytochrome c Reductase Complex Assembly Factor 2 (UQCC2) in a consanguineous Lebanese patient displaying complex III deficiency, severe intrauterine growth retardation, neonatal lactic acidosis and renal tubular dysfunction.
|
24385928 |
2013 |
Ganglioneuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Adult Hodgkin Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Childhood Hodgkin Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Childhood Ganglioneuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
|
28318056 |
2017 |
Chronic wasting disease (CWD)
|
0.010 |
Biomarker
|
disease |
BEFREE |
To further characterize an inoculum source used for ongoing CWD studies and to determine how the readouts from each of these assays compare, we assayed a CWD-positive brain pool homogenate (CBP6) and a mouse dilutional bioassay of this homogenate using the above detection methods.
|
31071138 |
2019 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Aggressive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
POLYDACTYLY, POSTAXIAL
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Metabolic acidosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Renal Tubular Acidosis, Type II
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Upward slant of palpebral fissure
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperactive behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Synophrys
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|